Academic Journal
The Erosion of a Pillar of Public Health: ACIP's Role and the Future of US Vaccine Policy Post-June 2025.
| Τίτλος: | The Erosion of a Pillar of Public Health: ACIP's Role and the Future of US Vaccine Policy Post-June 2025. |
|---|---|
| Συγγραφείς: | Asturias EJ; Departments of Pediatrics and Epidemiology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA., Schechter R; Immunization Branch, California Department of Public Health, Richmond, California, USA., Talbot HK; Nashville, Tennessee, USA., Boom J; Academic General Pediatrics, Texas Children's Hospital, Houston, Texas, USA., Brooks OT; College of Medicine, Charles R. Drew University of Medicine and Science, Los Angeles, California, USA., Chen LH; Department of Medicine, Mount Auburn Hospital and Harvard Medical School, Cambridge, Massachusetts, USA., Chu HY; Departments of Medicine and Epidemiology, University of Washington Schools of Medicine and Public Health, Seattle, Washington, USA., Cineas S; Departments of Medicine and Pediatrics, The Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA., Hawkinson DJ; Department of Medicine, University of Kansas School of Medicine, Kansas City, Kansas, USA., Kamboj M; Department of Infectious Diseases, Memorial Sloan Kettering Cancer Center, NewYork City, New York, USA., Loehr J; Cayuga Family Medicine, Ithaca, NewYork, USA., Lyons KL; Immunization Section, Illinois Department of Public Health, Springfield, Illinois, USA., Maldonado YA; Departments of Pediatrics and Medicine, Stanford University, Stanford, California, USA., Moser CA; Vaccine Education Center, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA., Roberts MW; Health Commissioner, Columbus, Ohio, USA., Shaw AC; Department of Medicine, Yale School of Medicine, New Haven, Connecticut, USA., Wiley Z; Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA., Zucker JR; Department of Community Health Sciences, SUNY Downstate School of Public Health, Brooklyn, NewYork, USA., Brewer NT; Department of Health Behavior, Gillings School of Global Public Health and Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina, USA. |
| Πηγή: | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2026 Jul 08; Vol. 82 (6), pp. 979-985. |
| Τύπος έκδοσης: | Journal Article; Research Support, Non-U.S. Gov't |
| Γλώσσα: | English |
| Στοιχεία περιοδικού: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE |
| Imprint Name(s): | Publication: Jan. 2011- : Oxford : Oxford University Press Original Publication: Chicago, IL : The University of Chicago Press, c1992- |
| Ιατρικοί όροι (MeSH): | Public Health*/legislation & jurisprudence , Health Policy*/trends , Advisory Committees*/organization & administration , Vaccination*/legislation & jurisprudence , Vaccines*, United States ; Humans ; Immunization Programs ; Policy Making |
| Περίληψη: | Since June 2025, the restructuring of the US Advisory Committee on Immunization Practices (ACIP)-including the abrupt replacement of all voting members and leadership-marked a significant departure from its longstanding norms of continuity and governance. Subsequent deviations from evidence-based policymaking raise concerns about the independence, transparency, and scientific rigor of vaccine policies under the new Department of Health and Human Services administration. The politicization of deliberations, selective use of questionable evidence, and disregard for established methodological standards threaten to undermine vaccine development, access, and public trust. Potential consequences include diminished credibility of federal vaccine recommendations, reduced advisory capacity for advancing key and new vaccines (eg, cytomegalovirus, Lyme disease), and disruption of critical and leading research infrastructure. Safeguarding ACIP's integrity through legislative and structural reforms is essential to restoring its credibility, preserving US leadership in global vaccine science, and maintaining population protection through robust, evidence-based immunization policy. (© The Author(s) 2026. Published by Oxford University Press on behalf of Infectious Diseases Society of America. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.) |
| Σχόλια: | Comment in: Clin Infect Dis. 2026 Jul 8;82(6):986-987. doi: 10.1093/cid/ciag043.. (PMID: 41607304) |
| Contributed Indexing: | Keywords: ACIP; United States; immunizations; science; vaccine policy |
| Substance Nomenclature: | 0 (Vaccines) |
| Entry Date(s): | Date Created: 20260129 Date Completed: 20260708 Latest Revision: 20260722 |
| Update Code: | 20260722 |
| DOI: | 10.1093/cid/ciag042 |
| PMID: | 41607311 |
| Βάση Δεδομένων: | MEDLINE |
| ISSN: | 1537-6591 |
|---|---|
| DOI: | 10.1093/cid/ciag042 |